Public summary documents – December 2022 PBAC meeting

6 April 2023 - The public summary documents (positive recommendations and subsequent decisions not to recommend) from the December 2022 PBAC ...

Read more →

MSAC Secretariat publishes agenda for July 2023 MSAC meeting

29 March 2023 - The MSAC Secretariat has published a list of applications scheduled to be considered by the MSAC ...

Read more →

Agenda for the July 2023 PBAC meeting

29 March 2023 - The agenda for the July 2023 PBAC meeting is now available. ...

Read more →

FDA outlines plan for digital health technologies for clinical trials

24 March 2023 - The US FDA plans to hold at least one public meeting and release several guidances on digital ...

Read more →

Advancing regulatory science in the EU – mid-point report published

22 March 2023 - The EMA has published a report summarising the mid-term achievements of its regulatory science strategy to ...

Read more →

Public Summary Documents (first time decisions not to recommend and deferrals) - November 2022 PBAC meeting

17 March 2023 - The Public Summary Documents (first time decisions not to recommend and deferrals) from the November 2022 PBAC ...

Read more →

DoH makes further tweaks to the agenda for this week's PBAC meeting

7 March 2023 - We are now at version 4 with four revisions. ...

Read more →

Public Summary Documents – November 2022 PBAC meeting (round 1)

3 March 2023 - The Public Summary Documents (positive recommendations and subsequent decisions not to recommend) from the November 2022 PBAC ...

Read more →

DoH tweaks the agenda for next week's PBAC meeting (2023/1)

3 March 2023 - We are now up to version 3; six revisions including two withdrawn submissions. ...

Read more →

ICER publishes evidence report on lecanemab for Alzheimer’s disease

1 March 2023 - Currently available evidence is rated as promising but inconclusive to determine whether lecanemab provides a net health ...

Read more →

MSAC publishes agenda for June 2023 ESC meeting

22 February 2023 - The MSAC Secretariat has published a list of applications scheduled to be considered by the ESC ...

Read more →

ICER publishes final evidence report on treatments for multiple sclerosis

21 February 2023 - Independent appraisal committee voted that evidence is not adequate to demonstrate a superior net health benefit ...

Read more →

EMA publishes agenda for 20-23 February 2023 CHMP meeting

20 February 2023 - The EMA has published a draft agenda for this week's CHMP meeting. ...

Read more →

ICER releases draft evidence report on treatments for non-alcoholic steatohepatitis

16 February 2023 - The ICER today released a draft evidence report assessing the comparative clinical effectiveness and value of resmetirom ...

Read more →

Updates from the Health Technology Assessment Policy and Methods Review Reference Committee (February 2023)

10 February 2023 - The Health Technology Assessment Policy and Methods Review Reference Committee met on 27 January 2023.  ...

Read more →